Novogen News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

21.03.22	KAZIA TO PRESENT AT UPCOMING INVESTOR CONFERENCE AND AACR ANNUAL SCIENTIFIC MEETING (PR Newswire)
28.02.22	PHASE II CLINICAL STUDY AT WEILL CORNELL MEDICAL CENTER INVESTIGATING PAXALISIB IN COMBINATION WITH METFORMIN AND A KETOGENIC DIET ENROLLS FIRST PATIENT (PR Newswire)
07.02.22	KAZIA THERAPEUTICS TO PRESENT AT BIO CEO CONFERENCE (PR Newswire)
25.01.22	KAZIA THERAPEUTICS TO PARTICIPATE IN EDISON GROUP'S GLOBAL HEALTHCARE 'OPEN HOUSE' VIRTUAL CONFERENCE (PR Newswire)
07.01.22	KAZIA THERAPEUTICS TO PRESENT AT HC WAINWRIGHT BIOCONNECT CONFERENCE (PR Newswire)
13.12.21	KAZIA THERAPEUTICS APPOINTS KAREN KRUMEICH AS CHIEF FINANCIAL OFFICER (PR Newswire)
04.12.21	Kazia Announces Positive Final Data From Phase II Clinical Study Of Paxalisib In Newly Diagnosed Glioblastoma (PR Newswire)
29.11.21	GBM AGILE Opens to Paxalisib in Canada (PR Newswire)
15.11.21	Kazia Therapeutics Appoints John Friend, MD, as Chief Medical Officer (PR Newswire)
11.11.21	PNOC Study in Childhood Brain Cancer Enrols First Patient (PR Newswire)
10.09.21	Kazia Therapeutics to Present at HC Wainwright 23rd Annual Global Investment Conference (PR Newswire)
21.07.21	Kazia Calls for Increased Focus on Brain Cancer Research this GBM Awareness Day (PR Newswire)
30.06.21	Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs (PR Newswire)
15.06.21	Kazia Enters Clinical Collaboration With Cornell University for Phase II Clinical Study Using Paxalisib in Combination With Ketogenic Diet for Glioblastoma (PR Newswire)
19.04.21	EVOTEC kooperiert mit Kazia Therapeutics bei Onkologie-Programm - EVOTEC-Aktie im Minus (Dow Jones) Der Biotechkonzern EVOTEC kooperiert in der Onkologie mit dem australischen Wettbewerber Kazia Therapeutics.» mehr
19.04.21	Evotec Reaches Licensing And Master Service Agreement With Kazia On Oncology (RTTNews)
09.12.20	Pre-market Movers In Healthcare Sector: RCKT, LPCN, PRPH, KZIA, CRIS… (RTTNews)
19.11.20	APVO Gets Buyout Offer, PFE/BNTX' COVID Shot 95% Effective, CORT Gets Favorable PTAB Ruling (RTTNews)
18.11.20	Pre-market Movers In Healthcare Sector: KZIA, LMNL, OCGN, INO, ONCT... (RTTNews)
18.11.20	BCLI Flunks Phase II ALS Study, LXRX Aces Sotagliflozin Trials, KZIA On Watch, FDA Snubs ALKS (RTTNews)
15.11.20	Week Ahead In Pharma: FDA Decisions, Data Readouts (ADMP, EIGR, KZIA, AVRO…) (RTTNews)
20.08.20	Pre-market Movers In Healthcare Sector: KZIA, TRVN, SNSS, OCGN, GLPG... (RTTNews)
10.08.20	Pre-market Movers In Healthcare Sector: TRVN, ETON, FENC, OPGN… (RTTNews)
07.08.20	Pre-market Movers In Healthcare Sector: KZIA, ZSAN, BNGO, VXRT, ADTX... (RTTNews)
07.04.20	Stock Alert: Kazia Therapeutics (KZIA) (RTTNews)
12.12.19	GILD's KTE-X19 To Face FDA, NTEC Drops As NVS Walks Away, KZIA On Watch (RTTNews)
30.01.19	6 Top Gainers In Healthcare Sector (OCX, KZIA, AVDL...) (RTTNews)
19.07.18	AVRO Up 21% In 3 Days, KZIA For The Long Haul, Big Test Awaits CHRS (RTTNews)
19.06.18	Kazia Releases Preliminary Cantrixil Phase I Data (PR Newswire)
19.06.18	Kazia Releases Preliminary Cantrixil Phase I Data (PR Newswire)
19.06.18	Kazia Releases Preliminary Cantrixil Phase I Data (PR Newswire)
29.03.18	Commencement de l'étude clinique en phase II du GDC-0084 (PR Newswire)
29.03.18	Start der klinischen Phase-II-Studie von GDC-0084 (PR Newswire)
29.03.18	Commencement Of Phase II Clinical Study Of GDC-0084 (PR Newswire)
29.03.18	Commencement Of Phase II Clinical Study Of GDC-0084 (PR Newswire)
29.03.18	Commencement Of Phase II Clinical Study Of GDC-0084 (PR Newswire)
26.02.18	KMPH Gets FDA Nod, ADMP On Track, OBSV To Report Data Today (RTTNews)
24.02.18	Kazia erhält Orphan-Kennzeichnung der FDA für GDC-0084 (PR Newswire)
23.02.18	Kazia reçoit la désignation de médicament orphelin de la FDA pour le GDC-0084 (PR Newswire)
23.02.18	Kazia Receives FDA Orphan Designation for GDC-0084 (PR Newswire)
23.02.18	Kazia Receives FDA Orphan Designation for GDC-0084 (PR Newswire)
23.02.18	Kazia Receives FDA Orphan Designation for GDC-0084 (PR Newswire)
31.01.18	KZIA Up 68% In 5 Days, APLS Bouncing Back, AKAO Clears A Hurdle, MDGL Abuzz (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Novogen Limited (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten